Mannose: study protocols
3 study groups say how much Mannose participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
510 products in our catalogue print how much Mannose a serving holds.
Most common: 500 mg to 1 g, 26% of 510 products.
| Dose per serving | Products |
|---|---|
| 25 mg or less | 15 |
| 25 mg to 50 mg | 43 |
| 50 mg to 100 mg | 83 |
| 100 mg to 250 mg | 71 |
| 250 mg to 500 mg | 68 |
| 500 mg to 1 g | 133 |
| 1 g to 2.5 g | 90 |
| over 2.5 g | 7 |
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
2 of 3 study groups took Mannose with something else, but nothing that 3 or more different studies gave.
3 study groups
| Study | |||
|---|---|---|---|
| D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial 2014 · D-mannose group · Women with recurrent urinary tract infections and no other significant comorbidities, following treatment for acute cystitis; age not stated | 2 g | 26 weeks | 103 |
| D-Mannose Plus Saccharomyces boulardii to Prevent Urinary Tract Infections and Discomfort after Cystoscopy: A Single-Center Prospective Randomized Pilot Study 2023 · Group A · Patients undergoing cystoscopy for suspected bladder cancer or follow-up after transurethral resection, with negative urine culture | 1 g | 6 days | 16 |
| [Efficacy and safety of D-mannose (2 g), 24h prolonged release, associated with Proanthocyanidin (PAC), versus isolate PAC, in the management of a series of women with recurrent urinary infections.] 2018 · Manosar® group · Women with non-complicated recurrent urinary tract infections; mean age 48 years | 2 g | 24 weeks | 44 |